Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue
+15.6%
EPS
−8.29%
Free cash flow
−37.2%
Total debt
−10.3%

Quarter to September 2026, against a year earlier

320.08 1.03 −0.32%
Market cap
$12.7B
P/E
80.3×
Fwd P/E
68.7×
Dividend yield
—
F-score
8/9
Altman Z
20.17
Beneish M
−2.48
Dividend safety
n/a

Penumbra, Inc. (PEN) Book value per share

Alert me on Book value per share

Penumbra, Inc.'s book value per share at the end of fiscal 2025 was 36.7×, up 23.1% from 29.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 40.2×. Over the past ten years it has ranged from 8.7× (fiscal 2016) to 36.7× (fiscal 2025) — the current reading is the highest in ten years. Penumbra, Inc. ranks 9th of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 36.7× 23.13%
FY2024 29.8× (2.97%)
FY2023 30.7× 16.31%
FY2022 26.4× 1.73%
FY2021 25.9× 45.51%
FY2020 17.8× 27.60%
FY2019 14.0× 12.93%
FY2018 12.4× 1.91%
FY2017 12.1× 38.77%
FY2016 8.7× (54.87%)

Quarterly newest first

Period Book value per share Change
Sep 2026 40.2× 3.32%
Jun 2026 38.9× 3.66%
Mar 2026 37.5× 2.30%
Dec 2025 36.7× 5.50%
43 more quarters

Against its own ten years

Low 8.7× High 36.7×
Ten-year median 19.4×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PEN